CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $22,876 | -32.7% | 207,025 | +0.0% | 0.00% | – |
Q3 2022 | $34,000 | -34.6% | 207,024 | 0.0% | 0.00% | – |
Q2 2022 | $52,000 | -52.7% | 207,024 | 0.0% | 0.00% | – |
Q1 2022 | $110,000 | -13.4% | 207,024 | 0.0% | 0.00% | – |
Q4 2021 | $127,000 | -46.9% | 207,024 | -11.5% | 0.00% | – |
Q3 2021 | $239,000 | -45.2% | 234,043 | -1.7% | 0.00% | -100.0% |
Q2 2021 | $436,000 | -20.7% | 238,024 | -54.7% | 0.00% | 0.0% |
Q1 2021 | $550,000 | +62.2% | 525,224 | +19.6% | 0.00% | 0.0% |
Q4 2020 | $339,000 | -23.3% | 439,024 | +67.6% | 0.00% | 0.0% |
Q3 2020 | $442,000 | -75.3% | 262,024 | +22.8% | 0.00% | -80.0% |
Q2 2020 | $1,790,000 | +60.3% | 213,324 | +0.1% | 0.01% | +25.0% |
Q1 2020 | $1,117,000 | +1.0% | 213,117 | +5.2% | 0.00% | +33.3% |
Q4 2019 | $1,106,000 | +14.1% | 202,511 | +1.8% | 0.00% | 0.0% |
Q3 2019 | $969,000 | -29.8% | 198,987 | -0.1% | 0.00% | -40.0% |
Q2 2019 | $1,380,000 | -16.5% | 199,098 | -16.3% | 0.01% | -16.7% |
Q1 2019 | $1,653,000 | +41.9% | 237,834 | +19.2% | 0.01% | +20.0% |
Q4 2018 | $1,165,000 | -23.6% | 199,571 | -1.1% | 0.01% | -16.7% |
Q3 2018 | $1,524,000 | +51.0% | 201,853 | +1.0% | 0.01% | +50.0% |
Q2 2018 | $1,009,000 | -16.7% | 199,821 | +0.6% | 0.00% | -20.0% |
Q1 2018 | $1,212,000 | -4.6% | 198,635 | +10.9% | 0.01% | 0.0% |
Q4 2017 | $1,271,000 | +2.1% | 179,050 | +2.8% | 0.01% | -16.7% |
Q3 2017 | $1,245,000 | +13.9% | 174,172 | +0.4% | 0.01% | 0.0% |
Q2 2017 | $1,093,000 | -20.6% | 173,475 | +3.9% | 0.01% | -25.0% |
Q1 2017 | $1,377,000 | 0.0% | 166,950 | +2.4% | 0.01% | 0.0% |
Q4 2016 | $1,377,000 | +23.9% | 162,967 | -0.4% | 0.01% | +14.3% |
Q3 2016 | $1,111,000 | +201.1% | 163,567 | +32.4% | 0.01% | +133.3% |
Q2 2016 | $369,000 | +6050.0% | 123,567 | +3886.0% | 0.00% | – |
Q1 2016 | $6,000 | +100.0% | 3,100 | +47.6% | 0.00% | – |
Q4 2015 | $3,000 | 0.0% | 2,100 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | – | 2,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |